Dr. Paula Muto reports

UBERDOC HEALTH TECHNOLOGIES APPOINTS LEMONAID HEALTH CO-FOUNDER PAUL JOHNSON TO ADVISORY BOARD AND CHANGES NAME TO APPTLY HEALTH TECHNOLOGIES CORP.

Apptly Health Technologies Corp. (formerly Uberdoc Health Technologies Corp.) has appointed Paul Johnson to its advisory board. Mr. Johnson co-founded Lemonaid Health, the first national direct-to-consumer telehealth service in the United States, and led it as chief executive officer through its $400-million (U.S.) sale to 23andMe in 2021.

Mr. Johnson built the model Uberdoc now extends to specialty care. Lemonaid put primary care in the consumer's pocket. Uberdoc connects patients directly to board-certified specialists at transparent prices, with no referrals, no insurance barriers and no surprise bills. Mr. Johnson's addition deepens the company's bench in consumer health care as it moves from a recent public listing into commercial scale.

"Paul did not just build a company, he built a category and he did it by betting that patients are consumers the moment the system lets them be," said Dr. Paula M. Muto, founder and interim chief executive officer of the company, and a practising vascular surgeon. "That is the same bet the company is making for specialty care. Having Mr. Johnson advising us as we scale strengthens our ability to execute with guidance from someone who has already navigated this path successfully."

"Apptly is attacking the access problem from the specialist side, where the cost and the friction concentrate," said Mr. Johnson. "A surgeon who still practises, who feels both the patient's frustration and the physician's, is exactly who should be building this. I am glad to help."

Mr. Johnson is a general partner at Flex Capital, a CEO coach, and an active investor and director across digital health. Before founding Lemonaid, Mr. Johnson ran on-line operations for one of the United Kingdom's largest pharmacy groups. The appointment continues a deliberate strengthening of the company's board and advisory bench, following the recent addition of John Dvor to the board of directors.

Name change

Further to its news release dated June 18, 2026, the company announces that it has also changed its name to Apptly Health Technologies. The common shares of the company will commence trading on the Canadian Securities Exchange under the new name at the opening of trading on June 23, 2026, under the existing ticker symbol APPT.

Following the name change, the new Cusip number of the common shares is 03790W 10 7 and the ISIN is CA 03790W 10 7 7. The name change will not affect the rights of the company's shareholders. There is no consolidation of capital associated with the name change and shareholders are not required to take any action in connection with the name change. Issued certificates representing common shares will not be affected by the name change and will not need to be exchanged.

Focus Communications engagement

The company has engaged Focus Communications Investor Relations Inc. (FCIR) to support its investor relations and corporate communications initiatives. Under the engagement, FCIR will provide investor outreach, shareholder communications, capital markets advisory and strategic communications services designed to increase the company's visibility among existing and prospective investors, and strengthen engagement with the investment community. In consideration for the services, FCIR will receive an aggregate payment of $60,000 (Canadian) over a six-month term commencing June 19, 2026, unless terminated earlier in accordance with the terms of the agreement. FCIR may provide additional services to the company in the future.

FCIR is a Toronto-based investor relations and communications firm. The firm provides strategic investor relations programs, shareholder communications, market awareness initiatives and capital markets advisory services to public and private companies.

FCIR and its principal, Leo Karabelas, are at arm's length to the company and have advised that they own 428,571 Common shares of the company.

FCIR has an address at 281 Village Green Dr., Woodbridge, Ont., L4L 9R3, and can be contacted at info@fcir.ca or by telephone at 647-689-6041.

About Apptly Health Technologies Corp. (formerly Uberdoc Health Technologies Corp.)

Apptly operates Uberdoc, a direct-pay health care marketplace that connects patients directly with board-certified specialists at transparent, upfront prices, with no referral requirements, no insurance barriers and no surprise bills. With more than 5,000 specialist physicians and clinicians across 55-plus specialties in all 50 states, the platform provides patients with faster access to care while enabling physicians to expand patient access and grow their practices. The company was founded by Dr. Paula M. Muto, MD.

We seek Safe Harbor.